Esperion Therapeutics (ESPR) Revenue Growth (1y) (2020 - 2026)
Esperion Therapeutics (ESPR) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.34% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.91% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.62% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 6.98% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 42.25% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 14.92% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -87.11% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 3.77% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.23% |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn | 23.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.25% |
| Dec 31, 2025 | 143.73% |
| Sep 30, 2025 | 69.10% |
| Jun 30, 2025 | 11.58% |
| Mar 31, 2025 | -52.81% |
| Dec 31, 2024 | 114.30% |
| Sep 30, 2024 | 52.00% |
| Jun 30, 2024 | 186.33% |
| Mar 31, 2024 | 466.14% |
| Dec 31, 2023 | 71.38% |
| Sep 30, 2023 | 78.97% |
| Jun 30, 2023 | 36.86% |
| Mar 31, 2023 | 29.16% |
| Dec 31, 2022 | 22.19% |
| Sep 30, 2022 | 31.72% |
| Jun 30, 2022 | -53.66% |
| Mar 31, 2022 | 136.10% |
| Dec 31, 2021 | 59.79% |
| Sep 30, 2021 | 275.92% |
| Jun 30, 2021 | -80.84% |